Hepatitis C Coinfection Enhances Sensitization of CD4 + T-Cells Towards Fas-Induced Apoptosis in Viraemic and Haart-Controlled HIV-1-Positive Patients

Ameisen J.C. , Capron A. Cell dysfunction and depletion in AIDS: the programmed celldeath hypothesis. Immunol Today 1991; 12: 102–105.

Krammer P.H. CD95's deadly mission in the immune system. Nature 2000; 407: 789–795.

Sun E.W. , Shi Y.F. Apoptosis: the quiet death silences the immune system. Pharmacol Ther 2001; 92: 135–145.

Hildeman D. , Jorgensen T. , Kappler J. , Marrack P. Apoptosis and the homeostatic control of immune responses. Curr Opin Immunol 2007; 19: 516–521.

Gougeon M.L. T cell apoptosis as a consequence of chronic activation of the immune system in HIV infection. Adv Exp Med Biol 1995; 374: 121–127.

Gougeon M.L. , Lecoeur H. , Dulioust A. Programmed cell death in peripheral lymphocytes from HIV-infected persons: increased susceptibility to apoptosis of CD4 and CD8 T-cells correlates with lymphocyte activation and with disease progression. J Immunol 1996; 156: 3509–3520.

Westendorp M.O. , Frank R. , Ochsenbauer C. Sensitization of T-cells to CD95-mediated apoptosis by HIV-1 Tat and gp120. Nature 1995; 375: 497–500.

Luciani F. , Matarrese P. , Giammarioli A.M. CD95/phosphorylated ezrin association underlies HIV-1 GP120/IL-2-induced susceptibility to CD95(APO-1/Fas)-mediated apoptosis of human resting CD4(+)T lymphocytes. Cell Death Differ 2004; 11: 574–582.

Poonia B. , Pauza C.D. , Salvato M.S. Role of the Fas/FasL pathway in HIV or SIV disease. Retrovirology 2009; 6: 91.

Anderson K.B. , Guest J.L. , Rimland D. Hepatitis C virus coinfection increases mortality in HIV-infected patients in the highly active antiretroviral therapy era: data from the HIV Atlanta VA Cohort Study. Clin Infect Dis 2004; 39: 1507–1513.

Greub G. , Ledergerber B. , Battegay M. Clinical progression, survival, and immune recovery during antiretroviral therapy in patients with HIV-1 and hepatitis C virus coinfection: the Swiss HIV Cohort Study. Lancet 2000; 356: 1800–1805.

Giordano T.P. , Kramer J.R. , Souchek J. , Richardson P. , El-Serag H.B. Cirrhosis and hepatocellular carcinoma in HIV-infected veterans with and without the hepatitis C virus: a cohort study, 1992-2001. Arch Intern Med 2004; 164: 2349–2354.

Pineda J.A. , Romero-Gómez M. , Díaz-García F. HIV coinfection shortens the survival of patients with hepatitis C virus-related decompensated cirrhosis. Hepatology 2005; 41: 779–789.

Kramer J.R. , Giordano T.P. , Souchek J. , El-Serag H.B. Hepatitis C coinfection increases the risk of fulminant hepatic failure in patients with HIV in the HAART era. J Hepatol 2005; 42: 309–314.

El-Serag H.B. , Giordano T.P. , Kramer J. , Richardson P. , Souchek J. Survival in hepatitis C and HIV co-infection: a cohort study of hospitalized veterans. Clin Gastroenterol Hepatol 2005; 3: 175–183.

Martín J.C. , Castilla J. , López M. , Arranz R. , González-Lahoz J. , Soriano V. Impact of chronic hepatitis C on HIV-1 disease progression. HIV Clin Trials 2004; 5: 125–131.

Rockstroh J.K. , Mocroft A. , Soriano V. Influence of hepatitis C virus infection on HIV-1 disease progression and response to highly active antiretroviral therapy. J Infect Dis 2005; 192: 992–1002.

Taya N. , Torimoto Y. , Shindo M. , Hirai K. , Hasebe C. , Kohgo Y. Fas-mediated apoptosis of peripheral blood mononuclear cells in patients with hepatitis C. Br J Haematol 2000; 110: 89–97.

Fischer R. , Baumert T. , Blum H. Hepatitis C virus infection and apoptosis. World J Gastroenterol 2007; 13: 4865–4872.

Körner C. , Krämer B. , Schulte D. Effects of HCV co-infection on apoptosis of CD4+ T-cells in HIV-positive patients. Clin Sci 2009; 116: 861–870.

Dianzani U. , Bensi T. , Savarino A. Role of FAS in HIV infection. Curr HIV Res 2003; 1: 405–417.

Katsikis P.D. , Wunderlich E.S. , Smith C.A. , Herzenberg L.A. , Herzenberg L.A. Fas antigen stimulation induces marked apoptosis of T lymphocytes in human immunodeficiency virus-infected individuals. J Exp Med 1995; 181: 2029–2036.

Aries S.P. , Schaaf B. , Müller C. , Dennin R.H. , Dalhoff K. Fas (CD95) expression on CD4+ T-cells from HIV-infected patients increases with disease progression. J Mol Med 1995; 73: 591–593.

Patki A.H. , Georges D.L. , Lederman M.M. CD4+-T-cell counts, spontaneous apoptosis, and Fas expression in peripheral blood mononuclear cells obtained from human immunodeficiency virus type 1-infected subjects. Clin Diagn Lab Immunol 1997; 4: 736–741.

Mitra D. , Steiner M. , Lynch D.H. , Staiano-Coico L. , Laurence J. HIV-1 upregulates Fas ligand expression in CD4+ T-cells in vitro and in vivo: association with Fas-mediated apoptosis and modulation by aurintricarboxylic acid. Immunology 1996; 87: 581–585.

Hosaka N. , Oyaizu N. , Than S. , Pahwa S. Correlation of loss of CD4 T-cells with plasma levels of both soluble form Fas (CD95) Fas ligand (FasL) in HIV-infected infants. Clin Immunol 2000; 95: 20–25.

Hosaka N. , Oyaizu N. , Kaplan M.H. , Yagita H. , Pahwa S. Membrane and soluble forms of Fas (CD95) and Fas ligand in peripheral blood mononuclear cells and in plasma from human immunodeficiency virus-infected persons. J Infect Dis 1998; 178: 1030–1039.

Llano A. , Barretina J. , Gutiérrez A. Interleukin-7 in plasma correlates with CD4 T-cell depletion and may be associated with emergence of syncytium-inducing variants in human immunodeficiency virus type 1-positive individuals. J Virol 2001; 75: 10319–10325.

Fluur C. , De Milito A. , Fry T.J. Potential role for IL-7 in Fas-mediated T cell apoptosis during HIV infection. J Immunol 2007; 178: 5340–5350.

Nunnari G. , Xu Y. , Acheampong E.A. Exogenous IL-7 induces Fas-mediated human neuronal apoptosis: potential effects during human immunodeficiency virus type 1 infection. J Neurovirol 2005; 11: 319–328.

Cianci R. , De Luca A. , Cammarota G. , Cauda R. , Pandolf F. HCV co-infection does not affect the TREC/IL-7 pathway in HIV disease. Eur Rev Med Pharmacol Sci 2008; 12: 67–69.

Soriano-Sarabia N. , Vallejo A. , Molina-Pinelo S. HIV-hepatitis C virus co-infection is associated with decreased plasmatic IL-7 levels. AIDS 2007; 21: 253–255.

Hayashi N. , Mita E. Involvement of Fas system-mediated apoptosis in pathogenesis of viral hepatitis. J Viral Hepat 1999; 6: 357–365.

Calabrese F. , Pontisso P. , Pettenazzo E. Liver cell apoptosis in chronic hepatitis C correlates with histological but not biochemical activity or serum HCV-RNA levels. Hepatology 2000; 31: 1153–1159.

Zignego A.L. , Giannini C. , Monti M. , Gragnani L. Hepatitis C virus lymphotropism: lessons from a decade of studies. Dig Liver Dis 2007; 39 Suppl 1: S38–S45.

Núñez M. , Soriano V. , López M. Coinfection with hepatitis C virus increases lymphocyte apoptosis in HIV-infected patients. Clin Infect Dis 2006; 43: 1209–1212.

Macías J. , Japón M.A. , Sáez C. Increased hepatocyte fas expression and apoptosis in HIV and hepatitis C virus coinfection. J Infect Dis 2005; 192: 1566–1576.

Munshi N. , Balasubramanian A. , Koziel M. , Ganju R.K. , Groopman J.E. Hepatitis C and human immunodeficiency virus envelope proteins cooperatively induce hepatocytic apoptosis via an innocent bystander mechanism. J Infect Dis 2003; 188: 1192–1204.

Roger P.M. , Breittmayer J.P. , Arlotto C. Highly active anti-retroviral therapy (HAART) is associated with a lower level of CD4+ T cell apoptosis in HIV-infected patients. Clin Exp Immunol 1999; 118: 412–416.

Dieye T.N. , Van Vooren J.P. , Delforge M.L. , Liesnard C. , Devleeschouwer M. , Farber C.M. Spontaneous apoptosis and highly active antiretroviral therapy (HAART). Biomed Pharmacother 2000; 54: 16–20.

Qurishi N. , Kreuzberg C. , Lüchters G. Effect of antiretroviral therapy on liver-related mortality in patients with HIV and hepatitis C virus coinfection. Lancet 2003; 362: 1708–1713.

Dyrhol-Riise A.M. , Stent G. , Røsok B.I. , Voltersvik P. , Olofsson J. , Asjö B. The Fas/FasL system and T cell apoptosis in HIV-1-infected lymphoid tissue during highly active antiretroviral therapy. Clin Immunol 2001; 101: 169–179.

Herbeuval J.P. , Nilsson J. , Boasso A. HAART reduces death ligand but not death receptors in lymphoid tissue of HIV-infected patients and simian immunodeficiency virus-infected macaques. AIDS 2009; 23: 35–40.

Caggiari L. , Zanussi S. , Bortolin M.T. Effects of therapy with highly active anti-retroviral therapy (HAART) and IL-2 on CD4+ and CD8+ lymphocyte apoptosis in HIV+ patients. Clin Exp Immunol 2000; 120: 101–106.

Ohnimus H. , Heinkelein M. , Jassoy C. Apoptotic cell death upon contact of CD4+ T lymphocytes with HIV glycoprotein-expressing cells is mediated by caspases but bypasses CD95 (Fas/Apo-1) and TNF receptor 1. J Immunol 1997; 159: 5246–5252.

Roggero R. , Robert-Hebmann V. , Harrington S. Binding of human immunodeficiency virus type 1 gp120 to CXCR4 induces mitochondrial transmembrane depolarization and cytochrome c-mediated apoptosis independently of Fas signaling. J Virol 2001; 75: 7637–7650.